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The Active Subunit of the Cytolethal Distending Toxin, CdtB, Derived From Both
Haemophilus ducreyi and Campylobacter jejuni Exhibits Potent
Phosphatidylinositol-3,4,5-Triphosphate Phosphatase Activity
Abstract
Human lymphocytes exposed to Aggregatibacter actinomycetemcomitans (Aa) cytolethal distending
toxin (Cdt) undergo cell cycle arrest and apoptosis. In previous studies, we demonstrated that the active
Cdt subunit, CdtB, is a potent phosphatidylinositol (PI) 3,4,5-triphosphate phosphatase. Moreover, AaCdttreated cells exhibit evidence of PI-3-kinase (PI-3K) signaling blockade characterized by reduced levels of
PIP3, pAkt, and pGSK3β. We have also demonstrated that PI-3K blockade is a requisite of AaCdt-induced
toxicity in lymphocytes. In this study, we extended our observations to include assessment of Cdts from
Haemophilus ducreyi (HdCdt) and Campylobacter jejuni (CjCdt). We now report that the CdtB subunit
from HdCdt and CjCdt, similar to that of AaCdt, exhibit potent PIP3 phosphatase activity and that Jurkat
cells treated with these Cdts exhibit PI-3K signaling blockade: reduced levels of pAkt and pGSK3β. Since
non-phosphorylated GSK3β is the active form of this kinase, we compared Cdts for dependence on
GSK3β activity. Two GSK3β inhibitors were employed, LY2090314 and CHIR99021; both inhibitors blocked
the ability of Cdts to induce cell cycle arrest. We have previously demonstrated that AaCdt induces
increases in the CDK inhibitor, p21CIP1/WAF1, and, further, that this was a requisite for toxin-induced cell
death via apoptosis. We now demonstrate that HdCdt and CjCdt also share this requirement. It is also
noteworthy that p21CIP1/WAF1 was not involved in the ability of the three Cdts to induce cell cycle arrest.
Finally, we demonstrate that, like AaCdt, HdCdt is dependent upon the host cell protein, cellugyrin, for its
toxicity (and presumably internalization of CdtB); CjCdt was not dependent upon this protein. The
implications of these findings as they relate to Cdt’s molecular mode of action are discussed. © Copyright
© 2021 Huang, Boesze-Battaglia, Walker, Zekavat, Schaefer, Blanke and Shenker.
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Human lymphocytes exposed to Aggregatibacter actinomycetemcomitans (Aa) cytolethal
distending toxin (Cdt) undergo cell cycle arrest and apoptosis. In previous studies, we
demonstrated that the active Cdt subunit, CdtB, is a potent phosphatidylinositol (PI) 3,4,5triphosphate phosphatase. Moreover, AaCdt-treated cells exhibit evidence of PI-3-kinase
(PI-3K) signaling blockade characterized by reduced levels of PIP3, pAkt, and pGSK3b.
We have also demonstrated that PI-3K blockade is a requisite of AaCdt-induced toxicity in
lymphocytes. In this study, we extended our observations to include assessment of Cdts
from Haemophilus ducreyi (HdCdt) and Campylobacter jejuni (CjCdt). We now report that
the CdtB subunit from HdCdt and CjCdt, similar to that of AaCdt, exhibit potent PIP3
phosphatase activity and that Jurkat cells treated with these Cdts exhibit PI-3K signaling
blockade: reduced levels of pAkt and pGSK3b. Since non-phosphorylated GSK3b is the
active form of this kinase, we compared Cdts for dependence on GSK3b activity. Two
GSK3b inhibitors were employed, LY2090314 and CHIR99021; both inhibitors blocked
the ability of Cdts to induce cell cycle arrest. We have previously demonstrated that AaCdt
induces increases in the CDK inhibitor, p21CIP1/WAF1, and, further, that this was a requisite
for toxin-induced cell death via apoptosis. We now demonstrate that HdCdt and CjCdt
also share this requirement. It is also noteworthy that p21CIP1/WAF1 was not involved in the
ability of the three Cdts to induce cell cycle arrest. Finally, we demonstrate that, like AaCdt,
HdCdt is dependent upon the host cell protein, cellugyrin, for its toxicity (and presumably
internalization of CdtB); CjCdt was not dependent upon this protein. The implications of
these ﬁndings as they relate to Cdt’s molecular mode of action are discussed.
Keywords: cytolethal distending toxin, host-parasite interactions, lymphocytes, toxins, pathogenesis, cell cycle
arrest, apoptosis
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demonstrated that as a consequence of Cdt-induced PI-3K
blockade, the downstream kinase, glycogen synthase kinase
3b (GSK3b), is activated; inhibitors of this kinase block toxininduced cell cycle arrest (Shenker et al., 2016). Another
signiﬁcant ﬁnding was that Cdt-induced increases in the
intracellular levels of the cyclin-dependent kinase (CDK)
inhibitor known as CDK-interacting protein (Cip1) and wildtype p53-activated fragment 1 (WAF1) (p21CIP1/WAF1) (Shenker
et al., 2020); repressed expression of this regulatory protein
blocks lymphocyte susceptibility to toxin-induced apoptosis.
The goal of this study was to determine if PIP3 phosphatase
activity was also expressed by and critical to lymphocyte toxicity
of other Cdts. In this study, we have assessed Hemophilus ducreyi
Cdt (HdCdt) and Campylobacter jejuni Cdt (CjCdt) for their
ability to both exhibit lipid phosphatase activity and induce PI3K signaling blockade in lymphocytes. Furthermore, HdCdt and
CjCdt were evaluated for similarities to AaCdt with respect to
their reliance on key proteins critical to toxicity; these include
GSK3b, p21CIP1/WAF1, and cellugyrin. It should be noted that
HdCdt was selected because its CdtB subunit shares >90%
homology with AaCdtB. In contrast, the CdtB subunit from
CjCdt shares only limited amino acid sequence and structural
homology with AaCdt and HdCdt; it shares greater homology
with CdtB derived from Escherichia coli Cdt.

INTRODUCTION
Cytolethal distending toxins (Cdt) represent a conserved and
highly distributed family of toxins produced by more than 30 gand ϵ- Proteobacteria. Collectively, these bacteria contribute to the
pathogenesis of a range of chronic infections and inﬂammatory
disorders that affect mucocutaneous tissue (reviewed in Smith and
Bayles, 2006; Scuron et al., 2016). Although Cdts are produced by a
diverse group of pathogens, there is considerable similarity
amongst the individual Cdts with respect to their range of toxic
activities; these include induction of both cell cycle arrest and
apoptosis in proliferating cell populations and induction of proinﬂammatory responses in macrophages (Smith and Bayles, 2006;
Guerra et al., 2011; Scuron et al., 2016). Consistent with these
observations is the ﬁnding that the active Cdt subunit, CdtB,
exhibits considerable amino acid sequence conservation within the
family of Cdts (Pons et al., 2019). Based upon these observations it
is reasonable to expect that the individual CdtB subunits that
comprise the diverse group of Cdt holotoxins would also share a
similar mechanism of action.
Two molecular modes of action have been proposed to
account for CdtB’s ability to induce both cell cycle arrest and
apoptosis. The long-standing paradigm is that CdtB, functioning
as a DNase, induces DNA damage that initially triggers
activation of the G2/M checkpoint and, in turn, induces cell
cycle arrest and eventually apoptosis (Cortes-Bratti et al., 2001a;
Frisan et al., 2002; Thelestam and Frisan, 2004). In some
instances, it has been proposed that cells surviving exposure to
Cdt are susceptible to a secondary effect leading to genetic
instability (Martin and Frisan, 2020). More recently, we
demonstrated a new paradigm for the molecular mode of
action for the Aggregatibacter actinomycetemcomitans Cdt
(AaCdt) in which CdtB functions as a potent lipid phosphatase,
depletes cells of the signaling lipid, phosphatidylinositol-3,4,5triphosphate (PIP3), and thereby induces blockade of the
ubiquitous PI-3K signaling pathway known to govern both cell
proliferation and survival as well as a number of other cell
functions (Shenker et al., 2007; Shenker et al., 2011; Shenker
et al., 2014; Scuron et al., 2016; Shenker et al., 2016). The evidence
for and against these modes of action has been reviewed in several
recent articles (Guerra et al., 2011; Scuron et al., 2016; Pons et al.,
2019). It is worth noting that both DNase and PIP3 phosphatase
function as phosphoesterases and belong to a larger family of
metalloenzymes each of which functions as a phosphoesterase
(Dlakic, 2000; Dlakic, 2001); the speciﬁc function of each of these
enzymes is likely to be largely dependent upon accommodation of
substrates within their active site. Thus, it is not surprising that
CdtB shares structural homology with both DNase I and inositol
polyphosphate-5-phosphatase (IP5P), all members of the
phosphoesterase superfamily (Shenker et al., 2007).
As noted above, we have reported extensively on the ability of
CdtB derived from AaCdt to function as a PIP3 phosphatase and
induce PI-3K signaling blockade. Importantly, we have
demonstrated the requirement for this enzymatic activity and
concomitant PI-3K signaling blockade in mediating both G2
arrest and apoptosis in human lymphocytes (Shenker et al., 2007;
Shenker et al., 2016a; Shenker et al., 2016b). Moreover, we have
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METHODS AND MATERIALS
Expression and Puriﬁcation of
Recombinant AaCdt, HdCdt, and EcCdt
In vitro expression of AaCdt peptides was performed using
the Rapid Translation System (RTS 500 ProteoMaster,
Sapphire North America; Ann Arbor, MI) as previously
described (Shenker et al., 2005). Reactions were run
according to the manufacturer’s speciﬁcation using 10-15 mg of
template DNA. After 20 hrs at 30°C, the reaction mix was
removed and the expressed Cdt peptides were puriﬁed by
metal ion afﬁnity chromatography (Shenker et al., 2005).
Construction and expression of the plasmid containing the
cdt genes for the Cdt holotoxin (pUCAacdtABChis)
have previously been reported (Boesze-Battaglia et al., 2009).
The histidine-tagged holotoxin was isolated by ion
afﬁnity chromatography.
HdCdt and CjCdt peptides were expressed using plasmid
constructed in the SRB lab and puriﬁed as previously described
(Eshraghi et al., 2010). Brieﬂy, E. coli BL21 were transformed
with Cdt-expressing plasmid in Luria-Bertani broth and
expression induced (OD600nm: 0.4-0.6) with isopropyl 1-thio-bD-galactopyranoside (Millipore Sigma Chemical Co; St. Louis,
MI). Three hr later cells were harvested, resuspended in PBS
containing 8 M urea and disrupted by sonication. Following
clariﬁcation by centrifugation, Cdt subunits were puriﬁed using
metal ion afﬁnity chromatography [Chelating Sepharose Fast
Flow; ThermoFisher; Waltham, MA)] and dialyzed as previously
described (Eshraghi et al., 2010). The purity of all peptides were
evaluated by SDS-PAGE and found to be >95% pure.
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dithiothreitol, 0.5 mM diC16-phosphatidylserine (Avanti Polar
Lipids; Alabaster, AL), 25 mM PIP3 (Echelon Inc; Salt Lake City,
UT) and the indicated amount of CdtB. Appropriate amounts of
lipid solutions were deposited in 1.5 ml tubes, organic solvent
removed, the buffer added and a lipid suspension formed by
sonication. Phosphatase assays were carried out at 37°C for
30 min; the reactions were terminated by the addition of 15 ml
of 100 mM N-ethylmaleimide. Inorganic phosphate levels were
then measured using a malachite green assay.

Cell Culture, Assessment of Cell Cycle
Arrest and Apoptosis
The T-cell leukemia cell line Jurkat (E6-1) was maintained as
previously described in RPMI 1640 supplemented with 10% FBS, 2
mM glutamine, 10 mM HEPES, 100 U/ml penicillin and 100 mg/
ml streptomycin (Shenker et al., 2004). Cells were harvested in
mid-log growth phase and plated as described below.
Jurkatp21CIP1/WAF1- and JurkatCg- cells were prepared using
CRISPR/CAS9 technology; the preparation and characterization
of these cells has been previously described (Boesze-Battaglia et al.,
2017; Shenker et al., 2020). Both cell lines were maintained in
medium containing puromycin (1 mg/ml); experiments were
conducted in medium without puromycin.
To measure Cdt-induced cell cycle arrest, cells (1 x 106) were
incubated for 24 hr and then washed and ﬁxed for 60 min with
cold 80% ethanol (Shenker et al., 2005). The cells were stained
with 10 µg/ml propidium iodide containing 1 mg/ml RNase
(Millipore Sigma Co) for 30 min. Samples were analyzed on a
Becton-Dickinson LSRII ﬂow cytometer (BD Biosciences; San
Jose, CA); a minimum of 15,000 events were collected for each
sample; cell cycle analysis was performed using Modﬁt (Verity
Software House; Topsham, ME).
Cdt-induced apoptosis was assessed following 48 hr
incubation in the presence of medium or Cdt by assessing
DNA fragmentation with the TUNEL assay (In Situ Cell Death
Detection Kit; (Millipore Sigma Co) (Shenker et al., 2001). Cells
were harvested and re-suspended in freshly prepared 4%
formaldehyde and permeabilized with 0.1% Triton X-100 for
2 min at 4°C. Cells were then washed with PBS and incubated in
a solution containing FITC labeled nucleotide and terminal
deoxynucleotidyl transferase (TdT) according to the
manufacturers speciﬁcations. FITC ﬂuorescence was assessed
by ﬂow cytometry as previously described (Shenker et al., 2001).

Statistical Analysis
Mean ± standard error of the mean were calculated for replicate
experiments. Signiﬁcance was determined using a Student’s ttest. Differences between multiple treatments were compared by
ANOVA paired with Tukey’s HSD posttest; a P-value of less than
0.05 was considered to be statistically signiﬁcant.

RESULTS
First, we investigated whether CdtB-associated lipid phosphatase
activity was restricted to AaCdtB or was instead a more universal
property of the family of Cdts that is also exhibited by the active
subunits of HdCdt and CjCdt. As shown in Figure 1, incubation
of each CdtB subunit with the substrate PIP3 resulted in a dosedependent (0.5-2.0 mM) release of phosphate. In the presence of
0.5, 1.0, and 2.0 mM HdCdtB, 0.35 ± 0.02, 0.68 ± 0.01, and 1.04 ±
0.05 nM phosphate was released, respectively; similar results
were observed with CjCdtB: 0.49 ± 0.03 (0.5 mM), 0.71 ± 0.02
(1.0 mM), and 1.09 ± 0.04 nM (2.0 mM) phosphate release. These
results indicate that both HdCdtB and CjCdtB exhibit PIP3
phosphatase activity that is comparable (~60-70%) to the

Western Blot Analysis of PI-3K Signaling
Blockade and pH2AX
Cells were treated as described and solubilized in 20mM TrisHCl buffer (pH7.5) containing 150 mM NaCl, 1mM EDTA, 1%
NP-40, 1% sodium deoxycholate and protease inhibitor cocktail
(Pierce). Samples (30 mg) were separated on 12% SDS-PAGE and
then transferred to nitrocellulose. Membranes were blocked with
BLOTTO and then incubated with one of the following primary
antibodies for 18 hr at 4°C (Shenker et al., 1999): anti-pAkt
(S473), anti pGSK3b (S9) (Cell Signaling Tech; Danvers, MA),
anti-pH2AX (Abcam; Cambridge, MA) or anti-GAPDH (Santa
Cruz Biotechnology). Membranes were incubated with goat antimouse immunoglobulin conjugated to horseradish peroxidase
(Southern Biotech Technology). The Western blots were
developed using chemiluminescence and analyzed by digital
densitometry (Li-cor Odyssey; Li-Cor Bio; Lincoln, NE).

FIGURE 1 | Assessment of the HdCdtB and CjCdtB subunits for PIP3
phosphatase activity. Varying amounts of CdtB derived from HdCdt and
CjCdt were assessed and compared to AaCdtB for their ability to hydrolyze
PIP3 as described in Materials and Methods. The amount of phosphate
release was measured using a malachite green binding assay. Data are
plotted as phosphate release (nM/30min;mean ± SEM) vs protein
concentration. Results are derived from three experiments each performed in
triplicate; *indicates statistical signiﬁcance (p < 0.01) relative to background
control samples (0.05 nM/30 min) not receiving protein samples.

Phosphatase Activity
Phosphatase activity was assessed by monitoring the
dephosphorylation of PIP3 as previously described (Maehama
et al., 2000; Shenker et al., 2007). Brieﬂy, the reaction mixture
(20 ml) consisted of 100 mM Tris-HCl (pH 8.0), 10 mM
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enzymatic activity observed with AaCdtB: 58 ± 0.04, 1.16 ± 0.02,
and 1.52 ± 003 nM phosphate release in the presence of 0.5,1.0,
and 2.0 mM of the subunit.
Following PIP3 depletion, control of cellular function by the
PI-3K signaling pathway is achieved by altering the
phosphorylation status of downstream kinases and
phosphatases, resulting in either their activation or inactivation
(Mitsiades et al., 2004; Huang and Sauer, 2010; Manning and
Toker, 2017). Two of these key downstream regulatory
components are the kinases protein kinase B (also known as
Akt) and GSK3b; both of these kinases are phosphorylated when
the PI-3K pathway is in an active state leading to Akt activation
and GSK3b inactivation. Consistent with CdtB’s ability to
function as a PIP3 phosphatase is its interference with PI-3K
signaling which includes reduced phosphorylation of both Akt
and GSK3b (Shenker et al., 2016). Speciﬁcally, we have
previously demonstrated that lymphocytes exposed to AaCdt
exhibit a signiﬁcant reduction in not only the levels of PIP3 but
also pAkt and pGSK3b at 2 and 4 hr. In the next series of
experiments, we determined whether HdCdt and CjCdt also
induced a similar blockade in the PI-3K pathway. Jurkat cells
were treated with medium or the nontoxic binding subunits
(CdtA + CdtC), serving as negative controls, and with the active
complex (CdtA + CdtB + CdtC). A representative Western blot is
shown in Figure 2A and demonstrates that cells exposed for 4 hr
to medium alone or to only the binding subunits failed to exhibit
signiﬁcant changes in the levels of Akt, pAkt, GSK3b or pGSK3b.
In contrast, when cells were treated with the active toxin complex
(CdtA + CdtB + CdtC) for the same time period they exhibited
reductions in both pAkt (S473) and pGSK3b (S9); total levels of
Akt and GSK3b remained unaltered. Figure 2B represents the
analysis of replicate experiments and indicates that in the
presence of HdCdt, pAkt and pGSK3b levels were signiﬁcantly
reduced to 41.8 ± 2.4% and 56.6 ± 20.4% of control levels.
Similarly, cells treated with CjCdt exhibited reduced levels of
these kinases to 34.8 ± 10.0% (pAkt) and 50.1 ± 11.9% (pGSK3b)
of control values. In previous studies, we have demonstrated, and
conﬁrm here, that Jurkat cells treated under identical conditions
with AaCdt exhibited signiﬁcantly reduced levels of both pAkt
(45.5 ± 11.6%) and pGSK3b (47.6 ± 6.1%) (Shenker et al., 2016).
Changes in the phosphorylation status of Akt and GSK3b
differentially alter their kinase activities. Non-phosphorylated
Akt is inactive and pAkt is active while phosphorylation of
GSK3b has the opposite effect, converting the kinase to its
inactive state. Indeed, we have demonstrated that Cdt-treated
Jurkat cells exhibit a 200% increase in GSK3b kinase activity;
furthermore, activation of GSK3b is a requisite for Cdt toxicity as
inhibitors of this kinase block toxin-induced cell cycle arrest
(Shenker et al., 2016). Therefore, we next determined if two
GSK3b inhibitors, LY2090314 and CHIR99021, could also block
HdCdt and CjCdt induced G2/M arrest (Figures 3A–K). Cells
exposed to medium alone exhibited 15.3 ± 1.2% cells in the G2/
M phases of the cell cycle; cells exposed to just the CdtA and
CdtC subunits exhibited similar levels of cells in the G2/M
phases (data not shown). As shown in Figs. 3B-3E, cells
exposed to the active AaCdt, HdCdt, and CjCdt complexes
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FIGURE 2 | Comparison of the effect of HdCdt and CjCdt with AaCdt on
phosphorylation of downstream components of the PI-3K signaling pathway.
Jurkat cells were treated with AaCdt (AaCdtA/C: 0.5 nM; AaCdtB: 5.7 nM),
HdCdt (HdCdtA/C: 0.2 nM; HdCdtB: 5.7 nM), and CjCdt (CjCdtA/C: 1.0 nM;
CdtB: 5.7 nM) for 2 hr and then assessed for levels of Akt, pAkt(S473),
GSK3ß and pGSK3ß(S9) by Western blot. (A) shows a representative
Western blot; (B) shows the compiled results of four experiments
(mean ± SEM); *indicates statistical signiﬁcance p < 0.05 when compared to
untreated control cells.

(CdtA+CdtB+CdtC) demonstrated signiﬁcant increases in cell
cycle arrest with 50.7 ± 10.8%, 50.1 ± 7.7%, and 40.4 ± 6.5% cells
in the G2/M phase, respectively. Pre-treatment of cells with the
GSK3b inhibitor LY2090314 (panels 3B, 3F-3H) reduced the
percentage of G2/M cells in the presence of Cdt to 19.6 ± 2.2%
(AaCdt), 16.4 ± 4.9% (HdCdt), and 17.1 ± 0.2% (CjCdt).
Similarly, pre-treatment with another GSK3b inhibitor,
CHIR99021 (panels 3B, 3I-3K), also reduced the percentage of
G2/M cells for all three toxins: 14.8 ± 4.1% (AaCdt), 15.1 ± 3.6%
(HdCdt), and 14.2 ± 3.6% (CjCdt).
Another key element in AaCdt-mediated toxicity involves the
role of the CDK inhibitor p21CIP1/WAF1 (Shenker et al., 2020).
Several studies, including our own, have demonstrated that
within 4 hrs of exposure to Cdt, cells exhibit increased levels of
p21CIP1/WAF1. Moreover, we have recently demonstrated that the
increase in p21CIP1/WAF1 was a requisite step for Cdt-induced
apoptosis (Shenker et al., 2020). Speciﬁcally, Jurkat cells deﬁcient
in p21CIP1/WAF1 expression (Jurkatp21CIP1/WAF1-) were found to
be refractory to AaCdt-induced apoptosis. To determine if this
dependence on p21CIP1/WAF1 extended to the other Cdts, we next
compared the susceptibility of Jurkat wildtype cells (JurkatWT)

4
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FIGURE 3 | Assessment of GSK3b inhibitors for ability to block Cdt-induced cell cycle arrest. Jurkat cells were pre-treated with medium, 25 µM LY2090314, or 50
µM CHIR99021 for 1 hr followed by the addition of AaCdt (130 pM holotoxin), HdCdt (HdCdtA/C: 0.2 nM; HdCdtB: 0.3 nM) or CjCdt (CjCdtA/C: 1.0 nM; CjCdtB:
1.2 nM). Cells were harvested 24 hr later and analyzed for cell cycle distribution using propidium iodide and ﬂow cytometry as described in Materials and Methods.
(A) shows the gating strategy to identify cell cycle distribution. Debris and cell doublets were gated out using plots of propidium iodide ﬂuorescence area versus
width (top panel; rectangle); analytical gates were set to identify cells in the G0/G1, S and G2/M phases of the cell cycle based upon propidium iodide ﬂuorescence
(bottom panel). The percentage (mean ± SEM) of G2/M cells from three experiments, each performed in duplicate is shown in panel (B); *indicates statistical
signiﬁcance (p<0.01) when compared to cells treated with toxin alone. Representative histograms are presented from a single experiment: panel (C–E) show the
results from cells pre-treated with medium only, panel (F–H) show results from cells pre-treated with LY2090314, and panel (I–K) show results from cells pre-treated
with CHIR99021. Cells exposed to medium alone exhibited 15.3 ± 2.1% G2/M cells. Panels (C, F, I) were treated with AaCdt, panels (D, G, J) were treated with
HdCdt and panels (E, J, K) were treated with CjCdt.
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with Jurkatp21CIP1/WAF1- cells to AaCdt, HdCdt and CjCdtinduced apoptosis. As shown in Figure 4A, JurkatWT cells
treated with the active toxin complex of AaCdt,HdCdt and
CjCdt exhibited a signiﬁcant increase in the percentage of
TUNEL positive (apoptotic) cells: 66.5 ± 4.7% (AaCdt) 72.9 ±
2.6% (HdCdt) and 50.2 ± 8.0% (CjCdt) over 2.6 ± 0.3% observed
with control (untreated) cells. In contrast, Jurkatp21CIP1/WAF1cells exhibited fewer apoptotic cells when exposed to AaCdt
(23.1 ± 3.6%), HdCdt (26.3 ± 4.1%) and CjCdt (8.4 ± 2.7%).
Untreated cells exhibited 3.3 ± 1.0% apoptotic cells.
In our previous study, we did not report on the relationship
between p21CIP1/WAF1 and Cdt-induced cell cycle arrest. In contrast
to Cdt-induced apoptosis, we observed that p21CIP1/WAF1
expression was not required for Cdt-induced cell cycle arrest. As
shown in Figure 4B, JurkatWT cells treated with Cdts exhibited 56.3
± 2.5% (AaCdt), 62.6 ± 1.9% (HdCdt), and 26.1 ± 0.9% G2/M cells
versus 15.3 ± 0.6% in untreated control cells. Jurkatp21CIP1/WAF1cells treated with the same dose of Cdts as the JurkatWT cells resulted
in similar percentages of cells in the G2/M phases: 57.3 ± 2.3%
(AaCdt), 60.1 ± 2.3% (HdCdt), and 27.6 ± 1.5% (CjCdt) compared
to 19.9 ± 0.1% in untreated control cells.
Intracellular levels of p21 C I P 1 / W A F 1 are controlled
transcriptionally, as well as post-translationally (Warfel and ElDeiry, 2013; Dutto et al., 2015). Previously, we demonstrated that
p21CIP1/WAF1 mRNA levels were not signiﬁcantly altered in
AaCdt-treated lymphocytes (Shenker et al., 2020); instead, we
observed that the increases were likely dependent upon posttranslational modiﬁcation as we have demonstrated a requisite
role for the chaperone protein, HSP90 (Shenker et al., 2020).
HSP90 has been shown to stabilize p21CIP1/WAF1 and prevent
proteasomal degradation (Jascur et al., 2005; Diehl et al., 2009).
Speciﬁcally, we have shown that geldanamycin A (GA), a HSP90
inhibitor, blocks both AaCdt-induced increases in p21CIP1/WAF1
and apoptosis. Based upon these observations, we utilized GA to
determine if HSP90 was also involved in HdCdt- and CjCdtinduced apoptosis. As shown in Figure 4C, JurkatWT cells
exposed to HdCdt and CjCdt exhibited 53.9 ± 7.2% and 33.2 ±
3.3% apoptotic (TUNEL positive) cells; control (untreated) cells
exhibited 2.5 ± 0.4% TUNEL positive cells. Pre-treatment with
GA reduced the percentage of apoptotic cells to 12.9 ± 3.5%
(HdCdt) and 19.9 ± 4.4% (CjCdt). Similar to our previous results
for AaCdt (Shenker et al., 2016) cells treated with AaCdt
exhibited 63.5 ± 8.9% apoptotic; pretreatment with GA
reduced the percentage to 11.2 ± 3.2% apoptotic cells.
It should also be noted that upregulation of p21CIP1/WAF1 may
also occur as a result of DNA damage (reviewed in Karimian et al.,
2016) which ultimately leads to activation of the DNA damage
response (DDR). DDR activation leads to concomitant activation of
the G2/M checkpoint and cell cycle arrest. Indeed, several
investigators have demonstrated that Cdts activate the DDR as
exempliﬁed by increased phosphorylation of the histone H2AX
(pH2AX), a commonly employed measure of DDR activation.
Increased pH2AX has been interpreted by several investigators as
not only an indicator of DDR activation, but also as a surrogate for
Cdt-mediated DNA damage (Bezine et al., 2014; Frisan, 2016). It
should be noted, however, that we previously demonstrated that
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FIGURE 4 | Assessment of the requirement for the CDK inhibitor p21CIP1/WAF1
in Cdt-induced toxicity. (A) JurkatWT cells and Jurkatp21CIP1/WAF1- were treated
with AaCdt, HdCdt and CjCdt (same concentrations as above) for 48hr and
then analyzed for apoptotic cells by determining the percentage of TUNEL
positive cells as detailed in Materials and Methods. The percentage of apoptotic
cells is plotted for both JurkatWT (solid bars) and Jurkatp21CIP1/WAF1- (cross
hatched bars) cells and represent the mean ± SEM of three experiments.
*indicates statistical signiﬁcance (p < 0.01) when compared to JurkatWT. (B)
JurkatWT cells and Jurkatp21CIP1/WAF1- were treated with AaCdt, HdCdt and
CjCdt for 16hr and assessed for the percentage of cells in the G2/M phase of
the cell cycle as described in Materials and Methods. The percentage of G2/M
cells is plotted for both JurkatWT (solid bars) and Jurkatp21CIP1/WAF1- (cross
hatched bars) cells and represent the mean ± SEM of three experiments. (C)
Jurkat cells were pre-treated with medium (solid bars) or Geldanamycin A [GA;
(cross-hatched bars)] for one hr before the addition of Cdt. Cells were analyzed
for apoptosis using the TUNEL assay 48 hr later; results represent the mean ±
SEM of three experiments. **indicates statistical signiﬁcance (p < 0.05).
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In the last series of experiments, we focused on recent
observations made involving the earliest stages of AaCdt
intoxication of host cells. Speciﬁcally, internalization of the CdtB
subunit has been shown to be dependent upon the host cell protein,
cellugyrin (synaptogyrin-2). Indeed, we have demonstrated that
soon after exposure to Cdt, intracellular molecular complexes form
that contain both CdtB and cellugyrin. Moreover, cells deﬁcient in
the expression of cellugyrin (JurkatCg-) were resistant to CdtB
internalization and intoxication (Boesze-Battaglia et al., 2017;
Boesze-Battaglia et al., 2020). Therefore, we explored whether
this dependence on cellugyrin also extended to HdCdt and
CjCdt. JurkatWT cells and JurkatCg- cells were compared for their
susceptibility to intoxication (both cell cycle arrest and apoptosis)
by HdCdt and CjCdt. Cells were treated with toxin for 24 hr and
then assessed for cell cycle distribution (Figure 6A). The
percentages of JurkatWT cells in the G2/M phase of the cell cycle
were 41.4 ± 2.0% (AaCdt), 50.0 ± 1.0% (HdCdt), and 33.0 ± 4.9%
(CjCdt) compared with 7.9 ± 0.6% in untreated cells. In contrast,
JurkatCg- cells exhibited signiﬁcant resistance to both AaCdt and
HdCdt, exhibiting reduced cells in the G2/M phase: 14.1 ± 0.3%
and 15.4 ± 1.0%, respectively; cells treated with CjCdt exhibited a
consistent, but not statistically signiﬁcant, reduction to 28.0 ± 5.1%.
Control JurkatCg- cells exhibited 13.5 ± 0.3% G2/M cells. Similar
results were observed when cells were assessed for toxin-induced
apoptosis (Figure 6B). Cells were treated with the same
concentration of toxin as was employed for cell cycle analysis,
but the analysis was performed at 48 hr. JurkatWT cells exhibited an
increase in TUNEL positive cells when exposed to each of the Cdts:
46.9 ± 9.1% (AaCdt), 72.2 ± 3.3% (HdCdt), and 21.5 ± 6.6%
(CjCdt) compared to 2.9 ± 0.5% in untreated control cells. In
comparison, JurkatCg- cells exposed to AaCdt and HdCdt exhibited
a signiﬁcant reduction in TUNEL positive cells: 1.9 ± 0.5% and
1.7 ± 0.5%, respectively; cells treated with CjCdt exhibited 20.8 ±
5.9%, similar to that observed with JurkatWT cells.

FIGURE 5 | Comparison of the effects of AaCdt, HdCdt, and CjCdt on
phosphorylation of H2AX. JurkatWT cells were incubated in the presence
AaCdt, HdCdt, and CjCdt (same concentrations as above) for one and four
hrs. Cells were then fractionated and analyzed by Western blot for the
presence of pH2AX. Etoposide-treated cells were used as a positive control.
A representative blot of three experiments is shown.

AaCdt-mediated p21CIP1/WAF1 upregulation in human lymphocytes
is not linked to activation of the DDR; the doses of AaCdt required
to induce cell cycle arrest (and apoptosis) do not induce increases of
pH2AX (Shenker et al., 2006; Shenker et al., 2016; Shenker et al.,
2020). Therefore, we also evaluated the effect HdCdt and CjCdt at
the doses employed in this study for their ability to induce increases
in pH2AX in lymphocytes. As shown in Figure 5, HdCdt and
CjCdt, like AaCdt, failed to induce increased levels of pH2AX at
these toxin concentrations at either 1 hr or 4 hr; exposure to
etoposide was employed as a positive control.

A

B

FIGURE 6 | Comparison of HdCdt and CjCdt for the requirement of the host cell protein cellugyrin to elicit toxicity. (A) JurkatWT (solid bars) and JurkatCg- (crosshatched bars) cells were treated with AaCdt, HdCdt, and CjCdt as described above for 16 hr and then assessed for cell cycle distribution. Results show the
percentage of cells in the G2/M phases of the cell cycle and are plotted as mean ± SEM of three experiments. (B) JurkatWT (solid bars) and JurkatCg- (cross-hatched
bars) cells were treated with AaCdt, HdCdt, and CjCdt for 48 hr and analyzed to determine the percentage of apoptotic cells using the TUNEL assay; results are
plotted as the mean ± SEM of three experiments. *indicates statistical signiﬁcance (p < 0.01) when compared to JurkatWT cells.
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blockade; the latter toxin exhibits less sequence homology but
similar structural motifs (Eshraghi et al., 2010; Scuron et al.,
2016). Indeed, we demonstrate that the CdtB subunits from both
HdCdt and CjCdt exhibit potent PIP3 phosphatase activity; this
activity was approximately 60% of that exhibited by AaCdtB.
Furthermore, Jurkat cells treated with each of these toxins exhibit
reductions in both pAkt and pGSK3b. These changes are
consistent with a molecular mechanism of action involving
PIP3 phosphatase activity associated with the induction of PI3K signaling blockade.
It should be noted that a critical observation that directly
relates to PI-3K signaling blockade is, as we previously
demonstrated, that AaCdtB-mediated reductions in pGSK3b
translate into measurable increases in enzymatic activity of this
kinase (Shenker et al., 2016). Furthermore, Cdt-induced cell
cycle arrest was found to be dependent upon GSK3b activation
as inhibitors of this kinase blocked G2/M cell arrest. In our
current study, we employed two GSK3b inhibitors, LY2090314
and CHIR99021, to determine if GSK3b activity was also
necessary for HdCdt and CjCdt. Our ﬁndings indicate that
HdCdt and CjCdt were also dependent upon GSK3b activity as
both inhibitors blocked the ability of these toxins to induce cell
cycle arrest, just as previously demonstrated for AaCdt (Shenker
et al., 2016).
Previously, we established a critical link between Cdtmediated PI-3K signaling blockade, the cell cycle regulatory
protein p21CIP1/WAF1, and toxin-induced apoptosis (Shenker
et al., 2020). Several investigators have demonstrated that
AaCdt, HdCdt, Helicobacter hepaticus Cdt and E. coli Cdt
induce increases in p21CIP1/WAF1 (Cortes-Bratti et al., 2001b;
Sato et al., 2002; Yamamoto et al., 2004; Graillot et al., 2016; PereVedrenne et al., 2017). We advanced these observations by
demonstrating that p21CIP1/WAF1 played a requisite role in Cdtinduced apoptosis; CdtB-associated lipid phosphatase is required
to induce the p21CIP1/WAF1 increases that are in turn required to
induce pro-apoptotic proteins (Shenker et al., 2020). Moreover,
cells deﬁcient in p21CIP1/WAF1 expression (Jurkatp21CIP1/WAF1-)
failed to express these pro-apoptotic proteins (Bid, Bax and Bak)
and concomitantly did not become apoptotic. We have now
extended these ﬁndings to include HdCdt and CjCdt as we
demonstrate that Jurkatp21CIP1/WAF1- cells also failed to become
apoptotic when exposed to these Cdts.
Also noteworthy is that Cdt-induced cell cycle arrest was not
dependent upon p21CIP1/WAF1 for all three Cdts. Jurkatp21CIP1/WAF1cells retained the capacity to undergo cell cycle arrest at levels
comparable with JurkatWT cells when treated with each of the Cdts.
In extended studies with AaCdt, we reported that the cells remained
in G2/M arrest for 48 and 72 hrs [further times were not assessed;
(Shenker et al., 2020)]. The dichotomous role of p21CIP1/WAF1 in
toxin-induced apoptosis versus cell cycle arrest is consistent with
our increasing knowledge of the diverse role(s) that this regulatory
protein plays in cell function. This includes a role that at times may
be pro-apoptotic and at other times anti-apoptotic; the survival
function of p21CIP1/WAF1 has been reported to be dependent, in part,
upon sub-cellular location and phosphorylation status (Kang et al.,
1999; Lincet et al., 2000; Gartel, 2005; Ghanem and Steinman, 2005;

DISCUSSION
Cdts represent a family of exotoxins that ﬁt the AB2 toxin model
in which the binding (B) subunit is comprised of subunits CdtA
and CdtC; the active (A) subunit is CdtB (Scuron et al., 2016).
The focus of our ongoing investigation into Cdt has been to
advance understanding of the virulence potential of AaCdt and
ultimately deﬁne CdtB’s molecular mode of action. In this
regard, many investigators have provided evidence in support
of a role for CdtB-associated DNase activity in contributing to
the underlying mode of action; the evidence (pro and con) for
this mechanism has been reviewed in several recent publications
(Cortes-Bratti et al., 2001; Frisan et al., 2002; Thelestam and
Frisan, 2004; Scuron et al., 2016). In contrast, our recent studies
have provided signiﬁcant evidence supporting a new paradigm
for the molecular mode of action in which CdtB interferes with
PI-3K signaling; this interference has been demonstrated for AaCdt
toxicity in host cells including lymphocytes, macrophages, and mast
cells (Shenker et al., 2007; Shenker et al., 2010; Shenker et al., 2014;
Shenker et al., 2016). Central to this mechanism of action is
AaCdtB’s ability to function as a PIP3 phosphatase similar to the
degradative enzymatic activities of the 3-phosphatase PTEN and the
5-phosphatase SHIP (Shenker et al., 2007).
PIP3 is a critical signaling lipid that is utilized by the PI-3K
signaling pathway; this pathway is critical to regulation of cell
growth, proliferation, and survival, as well as a number of other
functions that are speciﬁc to individual cell types (reviewed in
(Krystal, 2000; Mitsiades et al., 2004; Buckler et al., 2008; Huang and
Sauer, 2010; Manning and Toker, 2017)). In general, activation of
PI-3K leads to increased production of PIP3 and downstream
activation of the pathway; similarly, depletion of PIP3 results in
blockade of the pathway, leading to altered cell function(s) that is
typically opposite to the effect of pathway activation. A critical event
resulting from PIP3 depletion and representative of PI-3K blockade
is reduced phosphorylation of the kinases Akt and GSK3b; this
results in Akt inactivation and GSK3b activation. To date, we have
demonstrated that AaCdtB is a potent PIP3 phosphatase, and,
moreover, that AaCdt-treated lymphocytes exhibit signiﬁcant
reductions in PIP3 as well as pAkt and pGSK3b (Shenker et al.,
2007; Shenker et al., 2016). It should also be noted that PI-3K
blockade, in general, and decreases in the phosphorylation status of
these kinases, in particular, are consistent with Cdt toxicity observed
in human lymphocytes: decreased cell proliferation and cell survival.
Furthermore, these observations are mechanistically signiﬁcant as
Cdt holotoxin comprised of CdtB mutant proteins deﬁcient in
phosphatase activity also lack the ability to induce PI-3K blockade
and toxicity: cell cycle arrest and apoptosis (Shenker et al., 2016).
As noted earlier, the primary goal of this study was to
determine if the toxicity of other Cdts was dependent upon the
same critical events as those identiﬁed for AaCdt. This includes
assessment of CdtB subunits for PIP3 phosphatase activity and in
situ evidence that this enzymatic activity correlates with
concomitant changes associated with blockade of the PI-3K
signaling pathway in human lymphocytes. Speciﬁcally, we
assessed HdCdt, which has >95% sequence homology with
AaCdt along with CjCdt for their ability to induce PI-3K
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interpreted these ﬁndings as evidence of toxin-induced DNA
damage (Bezine et al., 2014; Frisan, 2016). However, we have
repeatedly demonstrated that the DDR is not activated (ie., we do
not observe increases in pH2AX) in lymphocytes under
conditions of AaCdt-treatment (Shenker et al., 2006; Shenker
et al., 2016; Shenker et al., 2020). In these studies, we employed
the minimum doses of toxin required to achieve maximum cell
cycle arrest and apoptosis. Under higher doses of toxin, we have
observed increases in pH2AX; however, these increases appear to
be the result of activation of the apoptotic cascade rather than a
direct effect of Cdt on DNA damage. For instance, over
expression of the anti-apoptotic protein Bcl-2, blocks Cdtinduced apoptosis and increases in pH2AX (Shenker et al.,
2006). We now demonstrate that under similar conditions,
neither HdCdt or CjCdt induce increases in lymphocyte levels
of pH2AX. These observations are consistent with AaCdt toxicity
and suggest that DDR, and hence, DNA damage, are not a
component of toxin induced cell cycle arrest and apoptosis in
lymphocytes. This raises the possibility that Cdts may utilize
different mechanisms in other cells, perhaps due to the

Abbas and Dutta, 2009; Giordano et al., 2017). Other investigators
have demonstrated that p21CIP1/WAF1 is a downstream target of
pAkt (Zhou et al., 2001; Li et al., 2002b; Zhou and Hung, 2002). In
the absence of pAkt, as occurs under CdtB-mediated PI-3K
signaling blockade, p21CIP1/WAF1 would not be phosphorylated,
thereby placing it into a pro-apoptotic mode. Indeed, this is what
we observed in previous studies (Shenker et al., 2020). Collectively,
these observations suggest that the induction of cell cycle arrest and
apoptosis may not be the consequence of sequential, interdependent
events; instead, they may be differentially regulated by altered
phosphorylation (activity) of downstream kinases of the PI-3K
signaling pathway (see Figure 7).
Intracellular levels of p21CIP1/WAF1 are typically low under
normal growth conditions while stress and/or DNA damage are
known to induce signiﬁcant increases. Elevated levels of p21CIP1/
WAF1
lead to activation of the DDR and G2 checkpoint; these
events contribute to cell cycle arrest and initially support survival
as cells attempt to repair DNA damage. Indeed, several
investigators have reported that Cdt-treated cells exhibit DDR
activation (i.e, phosphorylation of H2AX), and further, they have

FIGURE 7 | Schematic model showing proposed mechanism for CdtB internalization and toxicity in human lymphocytes. AaCdt, HdCdt, and CjCdt bind to cells via
cholesterol in the context of membrane lipid rafts. As a result of exposure to Cdt, cellugyrin-containing SLMVs translocate from cytosol to membrane lipid rafts. We
propose that this translocation leads to the association of AaCdtB and HdCdtB with the cellugyrin-containing SLMVs. This interaction may involve direct binding to
cellugyrin either on extra- or intra-vesicular loops or indirect association via an un-identiﬁed binding partner. We further propose that CdtB is transported via SLMVs
to intracellular target sites, such as locations containing PIP3 pools where the enzymatically active CdtB subunit is released from SLMVs and is then able to
dephosphorylate the signaling lipid, resulting in PI-3K blockade and toxicity. Based upon CjCdt toxicity independence of cellugyrin for toxicity (and presumably
internalization and trafﬁcking), we propose that CjCdtB enters through a cellugyrin- independent mechanism, hijacks retrograde transport mechanisms, and, in
lymphocytes, accumulates in sites of PIP3 pools similar to AaCdtB and HdCdtB.

Frontiers in Cellular and Infection Microbiology | www.frontiersin.org

9

March 2021 | Volume 11 | Article 664221

Huang et al.

Cdts Exhibit PIP3 Phosphatase Activity

blockade of this signaling pathway is also responsible for
increases in p21CIP1/WAF1 levels and all three of the Cdts are
dependent upon these increases to induce apoptosis, but not cell
cycle arrest. Clearly, our results do not eliminate a potential role
for of CdtB- associated DNase activity in mediating toxicity in
some host target cells.
In conclusion, we propose that Cdts represent a class of
virulence factors that contribute to the pathogenesis
of mucocutaneous infections caused by a wide range of
pathogens. The ability of one family of toxins, at least AaCdt,
HdCdt and CjCdt, to contribute to a diverse range of disease
pathogenesis is consistent with two molecular aspects of Cdt’s
mode of action. First, several Cdts utilize a ubiquitous receptor,
cholesterol, and are thereby able to bind, internalize and
intoxicate a wide range of cell types. Second, the PIP3
phosphatase activity exhibited by CdtB enables the toxin to
interfere with a universal signaling pathway that is utilized by
virtually all cells. The regulatory role that this pathway plays with
respect to individual cell function(s) dictates the adverse (and
varied) outcome of toxin-host cell interaction (reviewed in
Scuron et al., 2016). Thus, it is not surprising that Cdts have
been shown to promote infection by altering epithelial barrier
protection, promote inﬂammatory responses and impair
acquired immunity and thereby promote immune evasion. It
should be noted that all strains of bacteria do not express Cdt, yet
in some instances appear to share similar pathogenicity. Clearly,
this discrepancy needs further investigation as it may simply
reﬂect varying roles for Cdt under different conditions.
Alternatively, it is possible that studies conducted in animal
models often do not recapitulate all facets of disease; thus, it is
possible that the virulence of Cdt is less signiﬁcant under these
conditions. Nonetheless, it is intriguing to propose that
advancing our understanding of the molecular basis of Cdt
toxicity will provide the underpinnings for developing novel
approaches for pharmacologic intervention in treating infections
associated with Cdt-producing organisms.

requirement for higher doses of toxin to achieve toxicity. This
may explain, for example, that Cdt toxicity of some nonlymphoid cells such as epithelial cells may involve DDR
activation (Li et al., 2002a; Gargi et al., 2013; Ge et al., 2017;
Pere-Vedrenne et al., 2017). Clearly, this is a topic requiring
further investigation.
Previously, we demonstrated that p21CIP1/WAF1 increases were
not associated with a rise in mRNA levels and our observations also
exclude a role for DNA damage. Thus, our recent observations
regarding the role of heat shock protein HSP90 in AaCdt toxicity
are particularly relevant (Shenker et al., 2020). Mechanistically,
HSP90 has been shown to stabilize p21CIP1/WAF1 and thereby
prevent its degradation (Jascur et al., 2005; Diehl et al., 2009).
We now demonstrate another similarity between AaCdt and both
HdCdt and CjCdt as pretreatment of Jurkat cells with GA, a HSP90
inhibitor, blocked Cdt-induced apoptosis by both HdCdt and
CjCdt. It should also be noted that in previous studies we
determined AaCdtB-mediated increases in HSP90 were
dependent upon retention of its lipid phosphatase activity.
In a ﬁnal comparison of Cdts, the requirement for the host cell
protein, cellugyrin, was assessed. We have demonstrated
previously that shortly after holotoxin binding to human
lymphocytes and macrophages, CdtB is internalized via its
association with cholesterol rich membrane microdomains
(Boesze-Battaglia et al., 2006; Boesze-Battaglia et al., 2009;
Boesze-Battaglia et al., 2015; Boesze-Battaglia et al., 2016).
Internalization leads to an association of CdtB with cellugyrin, a
component of synaptic-like microvesicles (SLMVs) which may
participate in intracellular transport (Boesze-Battaglia et al., 2017;
Boesze-Battaglia et al., 2020). Moreover, reduced expression of
cellugyrin protects cells from CdtB internalization and subsequent
toxicity. Interestingly, in this study we demonstrate that HdCdt
shares a similar dependence on cellugyrin to that observed with
AaCdtB. In contrast, CjCdt did not exhibit a dependence on this
host cell protein as JurkatCg- cells exhibit comparable susceptibility
to toxicity, including both cell cycle arrest and apoptosis. These
ﬁndings suggest that AaCdt and HdCdt likely share similar modes
of internalization, and, possibly, retrograde transport while CjCdt
may utilize different pathways of entering cells and/or hijacking of
transport mechanisms (Figure 7). This interpretation is consistent
with the ﬁndings of Gargi et al. (Gargi et al., 2012; Gargi et al.,
2013), who demonstrated that HdCdt and EcCdt are transported
within cells by distinct pathways.
Our ﬁndings that CdtB from multiple Cdts is capable of
exhibiting lipid phosphatase activity are not surprising as this
subunit is expressed universally within the family of Cdts.
Moreover the “family” of CdtBs share similar amino acid
sequence homology and/or structural motifs, with respect to
catalytic domains (Dlakic, 2000; Dlakic, 2001). This study
expands our initial ﬁndings of a novel paradigm ﬁrst reported
for AaCdt for CdtB’s molecular mode of action (summarized in
Figure 7). The ability to exhibit PIP3 phosphatase activity and
induce PI-3K signaling blockade is clearly shared by HdCdt and
CjCdt. We propose that the toxic effect of these Cdts, at least with
respect to human lymphocytes, involves PI-3K signaling
blockade and dependence on GSK3b activation. Additionally,
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